GC Biopharma Corp. (KRX:006280)
126,400
-1,000 (-0.78%)
Last updated: Mar 28, 2025
GC Biopharma Revenue
In the year 2024, GC Biopharma had annual revenue of 1.68T KRW with 3.27% growth. GC Biopharma had revenue of 440.85B in the quarter ending December 31, 2024, with 8.87% growth.
Revenue
1,679.89B
Revenue Growth
+3.27%
P/S Ratio
0.85
Revenue / Employee
836.18M
Employees
2,009
Market Cap
1,425.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,679.89B | 53.25B | 3.27% |
Dec 31, 2023 | 1,626.64B | -84.67B | -4.95% |
Dec 31, 2022 | 1,711.31B | 173.49B | 11.28% |
Dec 31, 2021 | 1,537.83B | 33.71B | 2.24% |
Dec 31, 2020 | 1,504.12B | 147.00B | 10.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition